NASDAQ:CPRX   Catalyst Pharmaceuticals, Inc.
CPRX is a buy! Good P/E Ratio with a good growth profile. Stock is down because of the lawsuit which is not really a true competition.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.